In this study, we demonstrated that oncolytic Ads can elicit sufficient therapeutic efficacy on their own by expressing DCN, which induced both early and late stage apoptosis of tumor cells (Figures 2 and 6, Supplementary Figures 2 and 3). Here, DCN is linked to neoplasm.